Aptamers: The “evolution” of SELEX

Methods

Volumn 106, Issue , 2016, Pages 21-28

  Wu, Yi Xi ^a   Kwon, Young Jik ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Irvine   (United States)

Author keywords

Aptamers; SELEX

Indexed keywords

APTAMER;

AUTOMATION; BIOSENSOR; CHEMICAL STRUCTURE; GENE TARGETING; IN VITRO STUDY; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; REVIEW; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; GENETIC PROCEDURES; GENETICS; PROCEDURES;

APTAMERS, NUCLEOTIDE; BIOSENSING TECHNIQUES; SELEX APTAMER TECHNIQUE;

EID: 84999263587     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2016.04.020     Document Type: Review

References (86)

1. [1] Centi, S., Tombelli, S., Minunni, M., Mascini, M., Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads. Anal. Chem. 79 (2007), 1466–1473.
2. [2] Yang, C., Jockusch, S., Vicens, M., Turro, N.J., Tan, W., Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 17278–17283.
3. [3] Zhao, W., Chiuman, W., Brook, M.A., Li, Y., Simple and rapid colorimetric biosensors based on DNA aptamer and noncrosslinking gold nanoparticle aggregation. ChemBioChem, 2007.
4. [4] Bai, Y., Feng, F., Zhao, L., Wang, C., Wang, H., Tian, M., et al. Aptamer/thrombin/aptamer-AuNPs sandwich enhanced surface plasmon resonance sensor for the detection of subnanomolar thrombin. Biosens. Bioelectron. 47 (2013), 265–270.
5. [5] Xiao, Y., Lubin, A.A., Heeger, A.J., Plaxco, K.W., Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor. Angew. Chem. Int. Ed. Engl. 44 (2005), 5456–5459.
6. [6] Nutiu, R., Li, Y., Structure-switching signaling aptamers: Transducing molecular recognition into fluorescence signaling. Chemistry, 2004.
7. [7] Yamamoto, R., Kumar, P.K.R., Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV-1. Genes Cells, 2000.
8. [8] Cho, H., Baker, B.R., Wachsmann-Hogiu, S., Pagba, C.V., Laurence, T.A., Lane, S.M., et al. Aptamer-based SERRS sensor for thrombin detection. Nano Lett. 8 (2008), 4386–4390.
9. [9] Cunningham, E., Adamis, A., Altaweel, M., Aiello, L., Bressler, N., D'Amico, D., et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 (2005), 1747–1757.
10. [10] Ng, E.W.M., Shima, D.T., Calias, P., Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discovery 5 (2006), 123–132.
11. [11] Hamaguchi, N., Ellington, A., Stanton, M., Aptamer beacons for the direct detection of proteins. Anal. Biochem. 294 (2001), 126–131.
12. [12] Li, J.J., Fang, X., Tan, W., Molecular aptamer beacons for real-time protein recognition. Biochem. Biophys. Res. Commun. 292 (2002), 31–40.
13. [13] Ellington, A.D., Szostak, J.W., In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990), 818–822.
14. [14] Tuerk, C., Gold, L., Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (New York, N.Y.) 249 (1990), 505–510.
15. [15] Li, J., Fu, H.-E.E., Wu, L.-J.J., Zheng, A.-X.X., Chen, G.-N.N., Yang, H.-H.H., General colorimetric detection of proteins and small molecules based on cyclic enzymatic signal amplification and hairpin aptamer probe. Anal. Chem. 84 (2012), 5309–5315.
16. [16] Li, H., Zhang, Y., Luo, Y., Sun, X., Nano C60: a novel, effective, fluorescent sensing platform for biomolecular detection. Small 7 (2011), 1562–1568.
17. [17] Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C., Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20 (2002), 473–477.
18. [18] Giusto, D.D.A., Wlassoff, W.A., Gooding, J.J., Proximity extension of circular DNA aptamers with real-time protein detection. Nucleic Acids Res., 33, 2005.
19. [19] Heyduk, E., Heyduk, T., Nucleic acid-based fluorescence sensors for detecting proteins. Anal. Chem. 77 (2005), 1147–1156.
20. [20] Ngundi, M.M., Kulagina, N.V., Anderson, G.P., Taitt, C.R., Nonantibody-based recognition: alternative molecules for detection of pathogens. Expert Rev. Proteomics 3 (2006), 511–524.
21. [21] Tombelli, S., Minunni, M., Mascini, M., Aptamers-based assays for diagnostics, environmental and food analysis. Biomol. Eng. 24 (2007), 191–200.
22. [22] Stoltenburg, R., Reinemann, C., Strehlitz, B., FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem. 383 (2005), 83–91.
23. [23] Baird, G.S., Where are all the aptamers?. Am. J. Clin. Pathol. 134 (2010), 529–531.
24. [24] Liu, J., Cao, Z., Lu, Y., Functional nucleic acid sensors. Chem. Rev. 109 (2009), 1948–1998.
25. [25] Nitsche, A., Kurth, A., Dunkhorst, A., Pänke, O., Sielaff, H., Junge, W., et al. One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX. BMC Biotechnol., 7, 2007, 48.
26. [26] Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., et al. In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class. Proc. Natl. Acad. Sci. 99 (2002), 8898–8902.
27. [27] Pieken, W.A., Olsen, D.B., Benseler, F., Aurup, H., Eckstein, F., Kinetic characterization of ribonuclease-resistant 2’-modified hammerhead ribozymes. Science (New York, N.Y.) 253 (1991), 314–317.
28. [28] Burmeister, P.E., Lewis, S.D., Silva, R.F., Preiss, J.R., Horwitz, L.R., Pendergrast, P.S., et al. Direct in vitro selection of a 2’-O-methyl aptamer to VEGF. Chem. Biol. 12 (2005), 25–33.
29. [29] Lin, H., Zhang, W., Jia, S., Guan, Z., Yang, C.J., Zhu, Z., Microfluidic approaches to rapid and efficient aptamer selection. Biomicrofluidics, 8, 2014, 41501.
30. [30] Lou, X., Qian, J., Xiao, Y., Viel, L., Gerdon, A.E., Lagally, E.T., et al. Micromagnetic selection of aptamers in microfluidic channels. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 2989–2994.
31. [31] Bowser, M.T., SELEX: just another separation?. Analyst 130 (2005), 128–130.
32. [32] Klußmann, S., Nolte, A., Bald, R., Erdmann, V.A., Fürste, J.P., Mirror-image RNA that binds D-adenosine. Nat. Biotechnol. 14 (1996), 1112–1115.
33. [33] Nolte, A., Klussmann, S., Bald, R., Erdmann, V.A., Fürste, J.P., Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat. Biotechnol. 14 (1996), 1116–1119.
34. [34] Healy, J.M., Lewis, S.D., Kurz, M., Boomer, R.M., Thompson, K.M., Wilson, C., et al. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm. Res. 21 (2004), 2234–2246.
35. [35] Ng, E.W.M., Shima, D.T., Calias, P., Cunningham, E.T., Guyer, D.R., Adamis, A.P., Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discovery 5 (2006), 123–132.
36. [36] Griffin, L.C., Tidmarsh, G.F., Bock, L.C., Toole, J.J., Leung, L.L., In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 81 (1993), 3271–3276.
37. [37] Mosing, R.K., Bowser, M.T., Microfluidic selection and applications of aptamers. J. Sep. Sci. 30 (2007), 1420–1426.
38. [38] Cox, C.J., Rudolph, P., Ellington, A.D., Automated RNA Selection. Biotechnol. Prog., 14, 1998.
39. [39] Cox, J.C., Ellington, A.D., Automated selection of anti-protein aptamers. Bioorg. Med. Chem. 9 (2001), 2525–2531.
40. [40] Bunka, D.H.J., Mantle, B.J., Morten, I.J., Tennent, G.A., Radford, S.E., Stockley, P.G., Production and characterization of RNA aptamers specific for amyloid fibril epitopes. J. Biol. Chem. 282 (2007), 34500–34509.
41. [41] Ellingham, M., Bunka, D., Rowlands, D.J., Stonehouse, N.J., Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus. RNA 12 (2006), 1970–1979.
42. [42] Svobodova, M., Bunka, D.H.J., Nadal, P., Stockley, P.G., O'Sullivan, C.K., Selection of 2′F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications. Anal. Bioanal. Chem., 405, 2013.
43. [43] Eulberg, D., Buchner, K., Maasch, C., Klussmann, S., Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res., 33, 2005.
44. [44] Hybarger, G., Bynum, J., Williams, R.F., Valdes, J.J., Chambers, J.P., A microfluidic SELEX prototype. Anal. Bioanal. Chem. 384 (2006), 191–198.
45. [45] Lai, H.-C.C., Wang, C.-H.H., Liou, T.-M.M., Lee, G.-B.B., Influenza A virus-specific aptamers screened by using an integrated microfluidic system. Lab Chip 14 (2014), 2002–2013.
46. [46] Lin, H.-I.I., Wu, C.-C.C., Yang, C.-H.H., Chang, K.-W.W., Lee, G.-B.B., Shiesh, S.-C.C., Selection of aptamers specific for glycated hemoglobin and total hemoglobin using on-chip SELEX. Lab Chip 15 (2015), 486–494.
47. [47] Davies, D.R., Gelinas, A.D., Zhang, C., Rohloff, J.C., Carter, J.D., O'Connell, D., et al. Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 19971–19976.
48. [48] Vaught, J.D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., et al. Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132 (2010), 4141–4151.
49. [49] Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S., Hirao, I., Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat. Biotechnol. 31 (2013), 453–457.
50. [50] Benner, S.A., Understanding nucleic acids using synthetic chemistry. Acc. Chem. Res. 37 (2004), 784–797.
51. [51] Georgiadis, M.M., Singh, I., Kellett, W.F., Structural basis for a six nucleotide genetic alphabet. J. Am. Chem. Soc. 137 (2015), 6947–6955.
52. [52] Sefah, K., Yang, Z., Bradley, K.M., Hoshika, S., Jiménez, E., Zhang, L., et al. In vitro selection with artificial expanded genetic information systems. Proc. Natl. Acad. Sci. 111 (2014), 1449–1454.
53. [53] Yang, Z., Chen, F., Alvarado, B.J., Benner, S.A., Amplification, mutation, and sequencing of a six-letter synthetic genetic system. J. Am. Chem. Soc. 133 (2011), 15105–15112.
54. [54] Yang, Z., Chen, F., Chamberlin, S.G., Benner, S.A., Expanded genetic alphabets in the polymerase chain reaction. Angew. Chem. Int. Ed. 49 (2010), 177–180.
55. [55] Zhang, L., Yang, Z., Sefah, K., Bradley, K.M., Evolution of functional six-nucleotide DNA. J. Am. Soc. 137 (2015), 6734–6737.
56. [56] Sefah, K., Bae, K.-M.M., Phillips, J.A., Siemann, D.W., Su, Z., McClellan, S., et al. Cell-based selection provides novel molecular probes for cancer stem cells. Int. J. Cancer 132 (2013), 2578–2588.
57. [57] Zhang, K., Sefah, K., Tang, L., Zhao, Z., Zhu, G., Ye, M., et al. A novel aptamer developed for breast cancer cell internalization. ChemMedChem 7 (2012), 79–84.
58. [58] Berezovski, M., Drabovich, A., Krylova, S.M., Musheev, M., Okhonin, V., Petrov, A., et al. Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J. Am. Chem. Soc. 127 (2005), 3165–3171.
59. [59] Liu, Y., Wang, C., Li, F., Shen, S., Tyrrell, D.L., Le, X.C., et al. DNase-mediated single-cycle selection of aptamers for proteins blotted on a membrane. Anal. Chem. 84 (2012), 7603–7606.
60. [60] Drabovich, A., Berezovski, M., Krylov, S.N., Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J. Am. Chem. Soc. 127 (2005), 11224–11225.
61. [61] Mendonsa, S.D., Bowser, M.T., In vitro evolution of functional DNA using capillary electrophoresis. J. Am. Chem. Soc. 126 (2004), 20–21.
62. [62] Mendonsa, S.D., Bowser, M.T., In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal. Chem. 76 (2004), 5387–5392.
63. [63] Mendonsa, S.D., Bowser, M.T., In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. J. Am. Chem. Soc. 127 (2005), 9382–9383.
64. [64] Galas, D.J., Schmitz, A., DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res. 5 (1978), 3157–3170.
65. [65] Smith, S.E., Papavassiliou, A.G., A coupled Southwestern–DNase I footprinting assay. Nucleic Acids Res. 20 (1992), 5239–5240.
66. [66] Schütze, T., Wilhelm, B., Greiner, N., Braun, H., Peter, F., Mörl, M., et al. Probing the SELEX process with next-generation sequencing. PLoS ONE, 6, 2011.
67. [67] Ali, M.M., Aguirre, S.D., Lazim, H., Li, Y., Fluorogenic DNAzyme probes as bacterial indicators. Angew. Chem. Int. Ed., 2011.
68. [68] Klug, S.J., Famulok, M., All you wanted to know about SELEX. Mol. Biol. Rep. 20 (1994), 97–107.
69. [69] Beaudry, A.A., Joyce, G.F., Directed evolution of an RNA enzyme. Science, 1992.
70. [70] Lehman, N., Joyce, G.F., Evolution in vitro of an RNA enzyme with altered metal dependence. Nature Publishing Group, 1993.
71. [71] Famulok, M., Molecular recognition of amino acids by RNA-aptamers: an L-citrulline binding RNA motif and its evolution into an L-arginine binder. J. Am. Chem. Soc., 1994.
72. [72] Liu, Z., Mei, S.H., Brennan, J.D., Li, Y., Assemblage of signaling DNA enzymes with intriguing metal-ion specificities and pH dependences. J. Am. Chem. Soc. 125 (2003), 7539–7545.
73. [73] Sharma, A.K., Heemstra, J.M., Small-molecule-dependent split aptamer ligation. J. Am. Chem. Soc. 133 (2011), 12426–12429.
74. [74] Chiuman, W., Li, Y., Revitalization of six abandoned catalytic DNA species reveals a common three-way junction framework and diverse catalytic cores. J. Mol. Biol. 357 (2006), 748–754.
75. [75] Lee, J.F., Hesselberth, J.R., Meyers, L., Ellington, A.D., Aptamer database. Nucleic Acids Res., 32, 2004.
76. [76] Cruz-Toledo, J., McKeague, M., Zhang, X., Giamberardino, A., McConnell, E., Francis, T., et al. Aptamer base: a collaborative knowledge base to describe aptamers and SELEX experiments. Database, 2012, 2012.
77. [77] McKeague, M., McConnell, E.M., Cruz-Toledo, J., Bernard, E.D., Pach, A., Mastronardi, E., et al. Analysis of in vitro aptamer selection parameters. J. Mol. Evol. 81 (2015), 150–161.
78. [78] Ahirwar, R., Nahar, S., Aggarwal, S., Ramachandran, S., Maiti, S., Nahar, P., In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules. Sci. Rep., 6, 2016, 21285.
79. [79] Chushak, Y., Stone, M.O., In silico selection of RNA aptamers. Nucleic Acids Res., 37, 2009.
80. [80] Das, R., Karanicolas, J., Baker, D., Atomic accuracy in predicting and designing noncanonical RNA structure. Nat. Methods 7 (2010), 291–294.
81. [81] Detering, C., Varani, G., Validation of automated docking programs for docking and database screening against RNA drug targets. J. Med. Chem., 2004.
82. [82] Hoinka, J., Zotenko, E., Friedman, A., Sauna, Z.E., Identification of sequence-structure RNA binding motifs for SELEX-derived aptamers. Bioinformatics 28 (2012), 1215–1223.
83. [83] Jiang, P., Meyer, S., Hou, Z., Propson, N.E., Soh, H.T., MPBind: a Meta-motif-based statistical framework and pipeline to Predict Binding potential of SELEX-derived aptamers. Bioinformatics, 2014.
84. [84] Rahrig, R.R., Leontis, N.B., Zirbel, C.L., R3D Align: global pairwise alignment of RNA 3D structures using local superpositions. Bioinformatics, 2010.
85. [85] Sarver, M., Zirbel, C.L., Stombaugh, J., Mokdad, A., FR3D: finding local and composite recurrent structural motifs in RNA 3D structures. J. Math. Biol. 56 (2008), 215–252.
86. [86] Zhang, S., Kumar, K., Jiang, X., DOVIS: an implementation for high-throughput virtual screening using AutoDock. BMC Bioinformatics, 2008.